Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion

World Journal of Surgery

Volumn 37, Issue 5, 2013, Pages 1034-1042

  Nitta, Hidetoshi ^a   Beppu, Toru ^a   Imai, Katsunori ^a   Hayashi, Hiromitsu ^a   Chikamoto, Akira ^a   Baba, Hideo ^a,b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; DRUG ADMINISTRATION; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; LIVER VEIN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PORTAL VEIN; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION; VASCULAR TUMOR;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATIC VEINS; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM INVASIVENESS; PORTAL VEIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASCULAR NEOPLASMS;

EID: 84885655488     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-1957-1     Document Type: Article

References (35)

1. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
2. Poon D, Anderson BO, Chen LT et al (2009) Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 10:1111-1118
3. Ueno M, Uchiyama K, Ozawa S et al (2011) Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy. Ann Surg Oncol 8:3624-3631
4. Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200-207
5. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434-1440
6. Poon RT, Fan ST, Ng IO et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500-507
7. Ando E,Yamashita F, TanakaMet al (1997)Anovel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79:1890-1896
8. Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56:918-928
9. Pirisi M, Avellini C, Fabris C et al (1998) Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin 124:397-400
10. Masuda T, Beppu T, Ishiko T et al (2008) Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg 15:589-595
11. Fukuda S, Okuda K, Imamura M et al (2002) Surgical resection combined with chemotherapy for advanced hepatocellular carcinomawith tumor thrombus: report of 19 cases. Surgery 131:300-310
12. Ando E, Tanaka M, Yamashita F et al (2002) Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein: analysis of 48 cases. Cancer 95:588-595
13. Sakon M, Nagano H, Dono K et al (2002) Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94:435-442
14. Beppu T, Ohara C, Yamaguchi Y et al (1991) A new approach to hemoembolization for unresectable hepatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil. Cancer 68:2555-2560
15. Beppu T, Ishiko T, Chikamoto A et al (2012) Liver hanging maneuver decreases blood loss and operative time in a right-side hepatectomy. Hepatogastroenterology (in press)
16. Inoue Y, Hasegawa K, Ishizawa T et al (2009) Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery 145:9-19
17. The Liver Cancer Study Group of Japan (1994) Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74:2772-2780
18. Cady B (1983) Natural history of primary and secondary tumors of the liver. Semin Oncol 10:127-134
19. Llovet JM, Bustamante J, Castells A et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62-67
20. Minagawa M, Makuuchi M (2006) Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 21:7561-7567
21. Ikai I, Yamaoka Y, Yamamoto Y et al (1998) Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 227:433-439
22. Wu CC, Hsieh SR, Chen JT et al (2000) An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 135:1273-1279
23. Le Treut YP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature: a European case-control series. J Gastrointest Surg 10:855-862
24. Zhou J, Tang ZY, Wu ZQ et al (2006) Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterology 53:275-280
25. Choi KK, Kim SH, Choi SB et al (2011) Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 26:1646-1651
26. Minagawa M, Makuuchi M, Takayama T et al (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 233:379-384
27. Peng BG, He Q, Li JP et al (2009) Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 198:313-318
28. Niguma T, Muira T, Tutui N (2005) Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study. J Hepatobilliary Pancreat Surg 12:249-253
29. HuangYH,WuJC, LuiWYet al (2000) Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World J Surg 24:551-555. doi:10.1007/s002689910090
30. Ishida K, Hirooka M, Hiraoka A et al (2008) Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil. Jpn J Clin Oncol 38:596-603
31. Ikeda K, Saitoh S, Tsubota A et al (1993) Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71:19-25
32. Portolani N, Coniglio A, Ghidoni S et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229-235
33. Sakon M, Umeshita K, Nagano H et al (2000) Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 135:1456-1459
34. Yamanaka N, Okamoto E, Fujihara S et al (1992) Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer 70:2263-2267
35. Ichida F, Tsuji T, Omata M (1996) New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 6:112-119